Over the 90-day window ending January 14, 2026, COMPASS Pathways's three dominant insider ownership positions are held by TenPercentOwner Life Sciences N.V. Atai (6.91Mn shares), TenPercentOwner Ekaterina Malievskaia (6.31Mn shares), TenPercentOwner George Jay Goldsmith (6.31Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Life Sciences N.V. Atai | 6,905,774 | 27 Sep, 2024 | |
| Ekaterina Malievskaia | 6,307,970 | 25 Oct, 2024 | |
| George Jay Goldsmith | 6,307,970 | 25 Oct, 2024 | |
| Kabir Nath | Chief Executive Officer | 221,302 | 04 Aug, 2025 |
| Teri Loxam | Chief Financial Officer | 83,250 | 13 Mar, 2025 |
| Matthew A Owens | General Counsel & Clo | 43,340 | 05 Feb, 2024 |
| Michael Falvey | Chief Financial Officer | 22,500 | 03 Feb, 2023 |
| David Y Norton | 20,356 | 31 Mar, 2022 | |
| Annalisa Jenkins | 19,480 | 05 Aug, 2024 | |
| Guy Goodwin | Chief Medical Officer | 8,000 | 06 Apr, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 01 Aug, 2025 | Kabir Nath | Ordinary Shares | D | 6,366 | $4.34 | 221,302 | D | F |
| 11 Mar, 2025 | Teri Loxam | Ordinary Shares | A | 25,000 | $0.00 | 83,250 | D | A |
| 11 Mar, 2025 | Kabir Nath | Ordinary Shares | A | 92,000 | $0.00 | 227,668 | D | A |
| 03 Mar, 2025 | Teri Loxam | - | - | 58,250 | D | |||
| 03 Mar, 2025 | Teri Loxam | Ordinary Shares | D | 4,468 | $3.67 | 58,250 | D | F |
| 03 Feb, 2025 | Kabir Nath | Ordinary Shares | D | 15,516 | $4.31 | 135,668 | D | F |
| 24 Oct, 2024 | George Jay Goldsmith | Ordinary Shares | D | 776,565 | - | 3,155,122 | D | S |
| 24 Oct, 2024 | George Jay Goldsmith | Ordinary Shares | D | 776,565 | - | 3,152,848 | I | S |
| 24 Oct, 2024 | George Jay Goldsmith | - | - | 3,155,122 | D | |||
| 24 Oct, 2024 | Ekaterina Malievskaia | - | - | 3,155,122 | I | |||
| 24 Oct, 2024 | Ekaterina Malievskaia | Ordinary Shares | D | 776,565 | - | 3,152,848 | D | S |
| 24 Oct, 2024 | Ekaterina Malievskaia | Ordinary Shares | D | 776,565 | - | 3,155,122 | I | S |
| 26 Sep, 2024 | Life Sciences N.V. Atai | - | - | 6,905,774 | I | |||
| 26 Sep, 2024 | Life Sciences N.V. Atai | Ordinary Shares | D | 2,660,000 | $6.05 | 6,905,774 | I | S |
| 01 Aug, 2024 | Annalisa Jenkins | Ordinary Shares | D | 161 | $6.88 | 19,480 | D | F |
| 01 Aug, 2024 | Annalisa Jenkins | - | - | 19,480 | D | |||
| 01 Aug, 2024 | Kabir Nath | Ordinary Shares | D | 7,064 | $6.88 | 151,184 | D | F |
| 21 May, 2024 | George Jay Goldsmith | Ordinary Shares | D | 8,900 | $7.91 | 3,931,687 | D | S |
| 21 May, 2024 | George Jay Goldsmith | Ordinary Shares | D | 8,900 | $7.91 | 3,929,413 | I | S |
| 21 May, 2024 | George Jay Goldsmith | - | - | 3,931,687 | D |